Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Has anyone looked at the ticker ALPMF? The reason I ask is it closely mirrors ALPMY but trades separately.
I called my broker and he couldn't explain it. I called Astellas US company and the lady that answered said that Astellas is a Japanese company and I couldn't buy shares of Astellas in the USA. I explained that there are two ticker symbols for Astellas (ALPMY, ALPMF) and they both represent Astellas and I was wondering which one is the one affiliated with the Japanese Astellas that Robert Lanza is working for.
She said the person to answer that question was not in at the time, took my information and said someone would contact me soon. I haven't heard anything yet.
Maybe someone else can call their broker to see if they can get an answer or call Astellas US company at 800.888.7704 and share what they find out? Thanks in advance.
Ocata’s chief scientific officer to stay with Astellas following acquisition:
Robert Lanza, one of the most prominent scientists in the field of stem cell biology, Monday said he will lead global regenerative medicine research for Astellas Pharma Inc., the Japanese drug maker that acquired his Massachusetts-based company earlier this month.
Lanza said in an interview that he will also remain in his current role of chief scientific officer at Astellas-owned Ocata Therapeutics Inc. in Marlborough, which is developing stem cell therapies for a broad range of diseases.
https://www.bostonglobe.com/business/2016/02/22/ocata-chief-scientific-officer-join-astellas-head-global-regenerative-medicine/pptDFkpb3d6ei0b8x5PlKN/story.html
Then what were you paying 10 years ago? I would think your average would be lower than $6....
Hi,
Happy holidays....You know several years ago some of the best advice offered to me in regards to stock market investing was enjoy the market but try not to fall too much in love with one vested interest....
Kinda of makes cents and if you follow said advice it should help one from venting too much...
Share your opinion? Watcha think?
OK...Jezzebelll
Elysse,
I would worry not...so much...
All great a nut shell....
Enjoy the holidays.....
Yeah...I hear brother....
But umm....We are talking stocks...Not politics...
Kind of goes hand in hand though right...
Heck...didn't the interest rate just jump 0.5%?...>Something like that....To me, means bonds should go down but the market still up....I might be confused though...
Dude....Whew....I got 1/2 way reading that and then read your ending point....And yes.....I was confused too...
Bless you brother....I did the same you did, except I went 50/50...
Big Worm,
Very true...
What we do where I am at is eat the hottest stinkiest pepper ever....And slowly blow our breath downwind while waiting for a person to leave and then spread our fishing poles to catch what's left-over...haha..
I like that...
"Let me clarify"
LMAO
Huh...All I know is Astella could not buy any shares until 12.27.15....
Now they can....
Elysse,
TD said this:
"This offer expires on December 17, 2015, but to ensure adequate processing time we need to receive your instructions by December 15, 2015. Any instructions received after December 15, 2015 will be processed on a "Best Efforts" basis."
Ohh...The hail Mary part would be hoping (hail Mary) Astella ups their tender price on my remaining 50% I tendered...
If not I get them back and can choose to rebuy back in with the 50% I sold at market value if the pps drops like a rock....
You read that fluff news article where Lanza talking about lupus and MICE....haha....
Reminds me of how they would through that kind of stuff out to keep the shareholders enticed for years...
Perhaps he did that to keep Astella from walking away in a few weeks? Who knows anymore...
Thanks....Back to you....I'm happy with my Markel Holdings today...
Tendering costs approx $25 depending on your broker. Some are up to $38 in tender maintenance fees....Open market anywhere from $7 - $10 plus the deposit of your sales for cash out or re-investment is quicker on open market..
Personally, I'm thinking of selling 50% of my shares on the open market for a profit and tendering the other 50% hoping for a hail mary.
Huh? What did I just read?
Are you saying their will be a higher offer by Astella? or Someone else? What is this based on? Because OCATA broke a few pennies over $8.50 and then went back down close to $8.50?
Thank you very much Captain,
So, what are warrant laced options all about in regards to a company when they offer them like OCATA did?
In a nut shell version. I ask this because when I research and read it I don't understand it. But, the way you explain things I can understand easier.
Thanks in advance..
Kirk,
Does Astella acquire ALL of Ocata's debt? I know their close too zero debt, but uhmmm, as you call it, warrant laced options (never really understood what those were) along with their O/S once tendered by shareholders/institutions/fund managers for less than $400 Million?
As I understand at or near 25 November your broker has a fiduciary responsibility to send you information about the tender offer acquirement being offered. OCATA has no power over this.
It is then up to you to read what the tender offer means. At that point you have 20 days to read and decide to select yes or no to tender your shares.
If you select yes your shares will be converted as a sell minus the broker charge at $8.50 per share and the funds will be deposited as cash into your account with your broker.
If you select No then you still have 20 days to decide to sell or not. Regardless of your decision if Astella obtains 50% or 90% of the O/S (still waiting from North on that explanation) then it is a done deal and your broker will tender your shares at $8.50.
Unless you choose not to tender them. I guess at that point you can try to become part of a lawyer suit and see what happens...
However, I am not 100% sure what happens to your shares if Astella acquires 50-90% of the o/s and you decided not to tender them during the offer time frame?
But great question...And again do not take make advice as fact...I think the best to ask would be Captain Kirk (has previous working experience with these things) or a poster on this site named Nostradamus (In my experience he is usually spot on)..
Best to you...
North,
How do those warrant options work that OCATA has? Can they be released earlier than 25 November at a higher price than $8.50 to have them absolved?
I don't know you tell me? is it 90% of O/S shares need to be tendered for the acquisition to come to fruition? Or is 50% of the 1.7% that the BOD holds plus 1 BOD vote which is already done?
I'm just asking questions...Explain to me/us Mr. olie North..
Thanks in advance...
Not to shabby...nice....A win Win....
However, after all these years like me (not to be greedy) more would be fairer..
Elysse,
I apologize...I was looking at a different post link you responded too. I get your answer to my question from the post in question...All good....
Gotta love the slight breakout of over $8.50 though....If it holds perhaps some new news coming out soon...
Hopefully before Thanksgiving next week...
Reetala,
So your saying the 16.71% of no tender votes are ONLY from the ICell members and do not include institutional holders/ fund managers, others, etc?
If so, then wow, it could be a whole lot higher than 16.71% holding out. And doesn't Astella need 90% of the O/S to be tendered, not 50%? Or am I missing something?
I agree with the bankruptcy scenario if Astellas acquisition falls through. I kind of like your sports analogy on a lot of your posts, for example:
Experience leads me to know most good businesses will through out a low ball curve offer first to test the waters. If it doesn't pass the tender test they will try for second base by upping the tender offer and rarely need to go to third base.
At that point if they do need to go to third base and still can't garner 90% of the required O/S, will they, or will they not, attempt a home run to the pitchers plate?
I'm not sure. All depends on what they believe in from what they have seen from OCATA's portfolio I guess.
However, what question of mine are you referring too in the previous post? I thought they were all statements?
If true..
Then it's close let me see that would be 100% - 16.71% (against) = 83.29% (For) plus 1.71 (BOD holders For) = 85% for the acquisition to come to fruition.
WOW....Getting really close to the 90% required for the acquisition to occur.
Great question...
I would tender mine with a 20% increase of my average buy in price which was $6.00 pre-split...So, I guess at $8.50 I would make over 20%...
How about you?
I heard the same thing so it must be true...Say it ain't so...
Anyone know if large institutions/fund managers are able to invest in OTC companies like Astelas (ALPMY) or do they have to be listed on a major exchange before they can invest?
Thanks in advance.
$12 is the beginning....
LMAO,
Even the smartest people on the planet working for OCATA gave a recommendation to tender your shares before they go to absolute zero (0).....
They have your back brother...Please listen to the 3 wise men named (GR, PW & DA)...LMAO....
I tell my opinion,
PHASE II was never going to happen. They left out a lot on intel from phase 1 and never released the other patient data for a reason. In my humble opinion,,,'
And as CK aid, if OCATA had anything many large companies would absorb this 4348 plus change company faster than wonder woman circling her lasso around a make believe flying machine....
Kurt is correct, their approach (ocata slime) to AMD/SMD was going no-where ever and OCATA was lucky to find a Japanese company to buy it and sit on it......IMHOO....Boo...Hoo...
Another spin of the almighty coin that landed on a false shelf...
$544 WHA.....Hua....
Your joking/kidding right?
Common sense says Captain is right again....
Seems this will hover around $8ish until the closing date 0f $8.50.......
Then I recommend sell your 1:1 tenders at $8.50 to cover else break even depending on your buy-in/covering price...
OCATA is over...The Japanese company now owns all of what OCATA was...
I wonder if they really had anything? Or was just doing a humpty / dump?
Thanks Captain,
What you say makes a lot of sense. I was just wondering due to the below statements from Astellas, as it seems they want some of OCATA's team members to stay involved to meet their 2015-2017 Strategic Plan. Of course I have no more trust in OCATA's management.
"The acquisition of Ocata represents the coming together of two companies with significant accomplishments and a shared commitment to development innovative therapies that address the unmet medical needs of patients suffering from severe ophthalmic diseases. The acquisition also represents a step toward achieving Astellas' Strategic Plan 2015-2017.
Further, acquiring Ocata will enable Astellas to establish a presence in ophthalmology and a leading position in cell therapy.
"We highly value Ocata's R&D capabilities, including its world-leading researchers in cell therapy," commented Yoshihiko Hatanaka, President and CEO, Astellas. "We're confident that we will turn innovative science into value for patients through the creation of new value by combining both companies' capabilities under 'One Astellas,' where Ocata will be taking a key role in Astellas' R&D in ophthalmology and cell therapy."
http://finance.yahoo.com/news/astellas-acquire-ocata-therapeutics-030500707.html
ALPMY
They are currently trading at $14.55 with a $30.59 Billion dollar market cap and low debt.
If Astellas Pharmaceutical successfully acquires OCATA they would own all of OCATA's technology, patents, intellectual property, etc.
So, wouldn't taking your $8.50 per share after the acquisition and buying Astellas stock be prudent if OCATA really has a valid treatment that shows improvement for AMD/SMD?
Or am I missing something here?
I hear you. OCATA did break that $4.50 mark.
Time to update those hourly charts...